The FDA warned Corcept Therapeutics that it would face significant hurdles if it submitted its lead rare disease asset for ...
The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Zacks Investment Research on MSN
FDA accepts SMMT's application seeking approval for NSCLC drug
Summit Therapeutics SMMT announced that the FDA has accepted its biologics license application (BLA) seeking approval for ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...
GlobalData on MSN
Life Bio receives FDA approval for ER-100 clinical trial
The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy and open-angle glaucoma.
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results